Filana Therapeutics, Inc. (FLNA) Sharpe Ratio

Sharpe ratio is not yet available for FLNA. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.

How it compares to other similar stocks

The table compares Filana Therapeutics, Inc.'s Sharpe Ratio with other stocks in the Biotechnology industry across multiple time periods, showing how FLNA's risk-adjusted performance compares to industry peers.

Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jul 11, 2026.

Symbol	Name	1Y Sharpe Ratio
RVMDW	Revolution Medicines Inc. Warrant	16.50
ERAS	Erasca, Inc.	10.83
CLYM	Climb Bio Inc	9.65
SLGL	Sol-Gel Technologies Ltd.	8.17
DRTSW	Alpha Tau Medical Ltd. Warrant	8.12
STTK	Shattuck Labs, Inc.	7.49
SYRE	Spyre Therapeutics Inc.	7.45
ANRO	Alto Neuroscience, Inc	7.30
RLMD	Relmada Therapeutics, Inc.	7.29
LQDA	Liquidia Corporation	6.91
FLNA	Filana Therapeutics, Inc.	—

Benchmark Against

Benchmark

S&P 500 Index

Lookback Period

How to choose period

Historical Sharpe Ratio

The chart shows FLNA's rolling Sharpe ratio over time compared to your chosen benchmark. Rising trends indicate improving returns relative to total volatility, while declining trends may signal deteriorating risk-adjusted performance or increased volatility. Use multiple timeframes to distinguish short-term fluctuations from long-term patterns.

Identify market cycles by observing when FLNA consistently outperforms (line above benchmark), underperforms (below benchmark), or aligns with the benchmark.

Loading charts...

Sharpe Ratio Calculator

How does FLNA fit in your portfolio?

Add your other holdings to see your portfolio's Sharpe Ratio and find out.

Analyze Your Portfolio